跳至主要内容
临床试验/NCT06188793
NCT06188793招募中不适用

Evaluation of a Virtual Reality-Directed Brain Gut Behavioral Treatment Inpatient Program for Patients With Inflammatory Bowel Disease

University of Michigan1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年2月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
1
主要终点
Feasibility of the intervention measured as the frequency (percentage) of enrolled participants that complete the VR-directed BGBT inpatient program

研究概览

简要总结

The research is studying virtual reality (VR)-directed brain-gut behavioral therapy (BGBT) as a pain treatment option for hospitalized patients with inflammatory bowel disease (IBD). This study is being done to learn if VR-directed BGBT is feasible and acceptable for patients with IBD in addressing pain in the hospital setting.

The study hypothesizes that:

  • At least 75% of enrolled participants will complete the VR-directed BGBT inpatient program
  • Hospitalized patients with IBD will find VR-directed BGBT acceptable as a pain treatment option in the inpatient setting.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with Inflammatory Bowel Disease and self-reported pain
  • •Hospitalized for management of IBD (inpatient medicine services at Michigan Medicine)

排除标准

  • •Patients that do not report pain
  • •Anticipated length of hospital stay is less than 72 hours
  • •Patients that have previously had a seizure, loss of awareness, or other symptoms linked to an epileptic condition
  • •Patients with binocular vision loss
  • •Patients with an uncontrolled cardiac condition such as an arrhythmia, coronary artery disease, or neurological/cerebrovascular disease.
  • •Patients that are currently pregnant

研究组 & 干预措施

Virtual reality-directed BGBT

Experimental

干预措施: Virtual reality-directed BGBT (Device)

结局指标

主要结局

Feasibility of the intervention measured as the frequency (percentage) of enrolled participants that complete the VR-directed BGBT inpatient program

时间窗: 3 days of treatment

次要结局

  • Acceptability using the System Usability Scale - patients(Day 3 (post intervention))
  • Acceptability using the Treatment Acceptance and Adherence Scale- patients(Day 3 (post intervention))
  • Intervention acceptability based on qualitative data and collected from audio-recordings of semi-structured interview(1 week (semi-structured interview within 1 week of completion of the intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shirley Cohen-Mekelburg

Assistant Professor

University of Michigan

研究点 (1)

Loading locations...

相似试验